ResearcherSun Yat-sen UniversityActive in the last 2 years

Min Xiao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6237-4716; OpenAlex author ID A5080964592. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

A Candidate Small Molecule Targeting Tachykinin Receptor 1 Suppresses Substance P‑Driven Extracellular Signal-Regulated Kinase Activation and Tumor Innervation… Co-author DOI 10.1021/acsptsci.6c00306 ↗
Safety and Efficacy Analysis of PD-1 Inhibitors in Combination with Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer: A Real-World, Single-Center… Co-author DOI 10.2147/ott.s427942 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Arabella H. Wan · 1 shared paper, 2026 · strength 0.32
- Paper A Candidate Small Molecule Targeting Tachykinin Receptor 1 Suppresses Substance P‑Driven Extracellular Signal-Regulated… DOI 10.1021/acsptsci.6c00306 ↗
Qiyong Li · 1 shared paper, 2023 · strength 0.20
- Paper Safety and Efficacy Analysis of PD-1 Inhibitors in Combination with Gemcitabine Plus Nab-Paclitaxel for Advanced Pancre… DOI 10.2147/ott.s427942 ↗
Zhitao Chen · 1 shared paper, 2023 · strength 0.20
- Paper Safety and Efficacy Analysis of PD-1 Inhibitors in Combination with Gemcitabine Plus Nab-Paclitaxel for Advanced Pancre… DOI 10.2147/ott.s427942 ↗
Jun Chen · 1 shared paper, 2023 · strength 0.20
- Paper Safety and Efficacy Analysis of PD-1 Inhibitors in Combination with Gemcitabine Plus Nab-Paclitaxel for Advanced Pancre… DOI 10.2147/ott.s427942 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.